USPTO serial 86710586
HISCL
Reviewed by CopyMark Law Group
Reg. 5332394Status 710
- Filing date
- Status date
- Registration date
- Nov 14, 2017
- Examiner
- SNAPP, TINA LOUISE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with HISCL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Philip A. Jones
PHILIP A. JONES Brinks Gilson & LionePO Box 10395Chicago, IL 60610-0395UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents other than for medical or veterinary purposes; Chemical preparations for use in scientific and research purposes; Laboratory diagnostic chemicals for immunoassay analysis; Diagnostic reagents other than for medical or veterinary purposes; Diagnostic preparations other than for medical or veterinary purposes; Reagents and preparations used in blood testing for scientific or research purposes; Reagents for immunoassay analysis for scientific or research purposes; Reagents for hematology analysis for scientific or research purposes; Reagents for hemoglobin analysis for scientific or research purposes; Reagents for reticulocyte analysis for scientific or research purposes; Reagents for blood coagulation analysis for scientific or research purposes; Reagents for urinalysis for scientific or research purposes; Reagents for clinical chemistry testing for scientific or research purposes; Reagents for occult blood testing for scientific or research purposes; Reagents for genetic testing for scientific or research purposes; Chemical preparations for diluting blood samples or reagents for scientific or research use; Lysing solutions and/or reagents for scientific or research use; Hemolytic lysing solutions and/or reagents for scientific or research use; Chemical reagent stains for industrial use; Chemicals, namely, sheath solutions for industrial use; Chemical agents, namely, reference control materials for industrial use; Chemical agents, namely, chemical reference materials for industrial use; Chemical agents, namely, quality control standard solutions and quality control materials for industrial use for testing and calibrating medical apparatus and reagents; Chemical agents, namely, hematology control materials for industrial use | SECTION 8 - CANCELLED | — |
| 003 | Detergents for medical instruments use; Cleaning solutions for medical instruments use; Cleaning preparations; Cleaning solutions for diagnostic and testing apparatus; and Cleaning preparations for apparatus and instruments | SECTION 8 - CANCELLED | — |
| 005 | Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; Chemical reagents and chemical preparations for medical or veterinary purposes; Chemical reagents and chemical preparations for pharmaceutical purposes; Medical diagnostic reagents for immunoassay analysis; Medical diagnostic reagents for hematology analysis; Medical diagnostic reagents for blood analysis; Medical diagnostic reagents for hemoglobin analysis; Medical diagnostic reagents for reticulocyte analysis; Medical diagnostic reagents for blood coagulation analysis; Medical diagnostic reagents for urinalysis; Medical diagnostic reagents for urinary sediment analysis; Medical diagnostic reagents for bacteria analysis; Medical diagnostic reagents for clinical chemistry testing; Medical diagnostic reagents for occult blood testing; Medical diagnostic reagents for genetic testing; Diluents for blood samples, urine samples, bodily fluid samples, cell samples or reagents for medical and veterinary diagnostic purposes; Diluents for immunoassay analysis for medical or veterinary purposes; Diluents for hematology analysis for medical or veterinary purposes; Diluents for urinalysis for medical or veterinary purposes; Medical diagnostic lysing solutions and/or reagents; Medical diagnostic lysing solutions and/or reagents for immunoassay analysis; Medical diagnostic lysing solutions and/or reagents for hematology analysis; Medical diagnostic hemolytic lysing solutions and/or reagents; Medical diagnostic reagents, namely, stains for medical or clinical diagnostic use; Medical diagnostic reagents, namely, stains for immunoassay analysis; Medical diagnostic reagents, namely, stains for hematology analysis; Medical diagnostic reagents, namely, stains for urinalysis; Medical and veterinary diagnostic reagents, namely, sheath solutions; Medical and veterinary diagnostic reagents, namely, sheath solutions for immunoassay analysis; Medical and veterinary diagnostic reagents, namely, sheath solutions for hematology analysis; Medial and veterinary diagnostic reagents, namely, sheath solutions for urinalysis; Reference control materials for medical use; Chemical reference materials for medical use; Medical diagnostic preparations, namely, quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagents; Medical diagnostic preparations, namely, hematology control solutions for testing and calibrating apparatus and reagents; Hematology control preparations for medical use; Detergents for medical purposes | SECTION 8 - CANCELLED | — |
| 010 | Medical diagnostic apparatus and instruments for blood analysis; Medical diagnostic apparatus and instruments, namely, blood cell analyzers; Medical diagnostic apparatus and instruments for reticulocyte analysis; Medical diagnostic apparatus and instruments for blood coagulation analysis; Medical diagnostic apparatus and instruments for platelet aggregation analysis; Medical diagnostic apparatus and instruments for the pretreatment of blood; Medical diagnostic apparatus and instruments for non-invasive blood analysis; Medical diagnostic apparatus and instruments, namely, non-invasive blood vessel monitors, infrared spectroscopic analyzing apparatus and instruments, cell counters, blood cell counters, platelet counters, and particle counters; Medical diagnostic apparatus and instruments for urinalysis; Medical diagnostic apparatus and instruments for urine cell analysis; Medical diagnostic apparatus and instruments for urinary particle analysis; Medical diagnostic apparatus and instruments for the pretreatment of urine; Medical diagnostic apparatus and instruments for immunochemical analysis; Medical diagnostic apparatus and instruments for immunological testing; Medical diagnostic apparatus and instruments for immunoassay testing; Medical diagnostic apparatus and instruments for clinical chemistry analysis; Medical diagnostic apparatus and instruments for occult blood analysis; Medical diagnostic apparatus and instruments for bacteria analysis; Medical diagnostic apparatus and instruments for genetic testing; Medical diagnostic apparatus and instruments for gene amplification analysis; Medical diagnostic apparatus and instruments for cancer lymphatic metastasis analysis; Medical diagnostic apparatus and instruments, namely, blood diluting devices, blood collecting devices, blood sampling tubes, pipettes, needles, smear test sample making devices, glass slides, shakers and rolling mixers, centrifuges, respioratory aspirators, pulse measuring devices, sphygmomanometers, sample containers for in vitro diagnosis, medical sample bottles, disposable beakers, disposable cups for urinalysis, blood collecting tubes, beaker stands, and test tube stands | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks owned by Sysmex Corporation
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named HISCL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 28, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 14, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 14, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 29, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 9, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 21, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 11, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 3, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Dec 21, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 16, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 14, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 18, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 17, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 17, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 15, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 15, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 15, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 22, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 22, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 12, 2015 | ALIE | ASSIGNED TO LIE | — |
| Sep 8, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2015 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 5, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 3, 2015 | NWAP | NEW APPLICATION ENTERED | — |